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Abstract
The innate immune system provides immediate defense against infection and serves as the
first line of host defense during infection. In innate immunity, leukocytes such as neutrophils and
macrophages recognize and respond to pathogens in a non-specific manner. Therefore, the recruit-
ment and activation of leukocytes are essential in innate immunity, and are governed by a variety
of chemical mediators including cytokines. Cytokines are generally divided into 2 types, termed
type-1 and type-2 cytokines. Type-1 cytokines are important in local host defense, while type-2
cytokines play a protective role when inflammatory response spreads to the body. These cytokines
exert their biological functions through the janus kinase/signal transducer and activator of tran-
scription (JAK/STAT) pathway. STAT1/3/4/6 are transcription factors that mediate IFNgamma/IL-
10/IL-12/IL-13 cytokine signaling, respectively. Evidence indicates that STAT proteins have a sig-
nificant impact on innate immunity during sepsis. This review focuses on recent understandings in
the regulation of innate immunity by STAT proteins during sepsis and septic shock. The suppres-
sor of cytokine signaling (SOCS) proteins are a family of SH2 domain-containing cytoplasmic
proteins that complete a negative feedback loop to attenuate signal transduction from cytokines
that act through the JAK/STAT pathway. The participation of SOCS proteins in sepsis is also
discussed.
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ur environment contains a great variety of 
infectious microbes,  which may be potentially 
destructive and can threaten our survival.  As soon as 
microbes try to establish a site of infection,  the host 
launches a complex defense system.  Leukocyte inﬁ l-
tration into the site of infection and the subsequent 
activation of the cells are the fundamental host 
defenses during sepsis,  during which inﬁ ltrating leu-
kocytes inactivate and clear the invading pathogens 
[1,  2].  Thus,  inﬂ ammation is primarily a beneﬁ cial 
host response to infection.  However,  inﬂ ammation is 
also harmful depending on the circumstances,  as an 
excessive and prolonged response can cause tissue 
damage,  resulting in fatal organ failure [3,  4].  
Therefore,  the response must be under the strict con-
trol of endogenous mechanism (s).  An imbalance in the 
cytokine response may allow infection to become 
established or may result in an uncontrolled systemic 
inﬂ ammatory response [5,  6].
　 Cytokines utilize complex signaling cascades to 
elicit their biological eﬀ ects.  Many of these cytokines 
exert their biological functions through the janus 
O
The innate immune system provides immediate defense against infection and serves as the ﬁ rst line of 
host defense during infection.  In innate immunity,  leukocytes such as neutrophils and macrophages 
recognize and respond to pathogens in a non-speciﬁ c manner.  Therefore,  the recruitment and activa-
tion of leukocytes are essential in innate immunity,  and are governed by a variety of chemical media-
tors including cytokines.  Cytokines are generally divided into 2 types,  termed type-1 and type-2 cyto-
kines.  Type-1 cytokines are important in local host defense,  while type-2 cytokines play a protective 
role when inﬂ ammatory response spreads to the body.  These cytokines exert their biological functions 
through the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.  
STAT1/3/4/6 are transcription factors that mediate IFNｺ/IL-10/IL-12/IL-13 cytokine signaling,  
respectively.  Evidence indicates that STAT proteins have a signiﬁ cant impact on innate immunity dur-
ing sepsis.  This review focuses on recent understandings in the regulation of innate immunity by 
STAT proteins during sepsis and septic shock.  The suppressor of cytokine signaling (SOCS) proteins 
are a family of SH2 domain-containing cytoplasmic proteins that complete a negative feedback loop to 
attenuate signal transduction from cytokines that act through the JAK/STAT pathway.  The partici-
pation of SOCS proteins in sepsis is also discussed.
Key words: cytokines,  innate immunity,  sepsis,  SOCS,  STAT
Acta Med.  Okayama,  2007
Vol.  61,  No. 5,  pp.  239ﾝ245
http ://www.lib.okayama-u.ac.jp/www/acta/
CopyrightⒸ 2007 by Okayama University Medical School.
Review
Received April 20, 2007 ; accepted May 11, 2007.
 Corresponding author. Phone : ＋81ﾝ86ﾝ235ﾝ7141; Fax : ＋81ﾝ86ﾝ235ﾝ7141
E-mail : amatsu@md.okayama-u.ac.jp (A. Matsukawa)
1
Matsukawa: STAT Proteins in Innate Immunity during Sepsis: Lessons from Gene
Produced by The Berkeley Electronic Press, 2007
kinase/signal transducer and activator of transcrip-
tion (JAK/STAT) pathway [7,  8].  The importance 
of the JAK/STAT pathway in regulating cytokine 
signaling has been well established by the targeted 
disruption of genes encoding STATs [9].  On the 
other hand,  suppressor of cytokine signaling (SOCS) 
proteins are negative regulators of cytokine signaling 
that act by inhibiting the JAK/STAT signal transduc-
tion pathway [10].  This review focuses on the bio-
logical signiﬁ cance of STAT/SOCS proteins during 
sepsis and septic shock.
Sepsis and Septic Shock
　 Sepsis is an infection-induced syndrome,  and its 
clinical manifestations are usually the consequence of 
intense cellular interactions.  Sepsis may initially be 
caused by a local infection,  the frequent sites of which 
are the lungs,  urinary tract,  and abdomen [11,  12].  
The ﬁ rst host response against invading pathogens 
involves the recruitment and activation of leukocytes 
at infectious foci,  thus allowing these cells to success-
fully localize,  kill and clear the pathogens.  However,  
once the host fails to limit microbes to a local area,  
microbes may invade into bloodstream and their prod-
ucts then trigger an excessive and prolonged inﬂ amma-
tory response via the overzealous production of 
inﬂ ammatory mediators including cytokines,  which can 
become pathologic,  self-destructive,  and,  at times,  
can be more fatal than the original inciting pathogens 
[6,  11].  A typical example is systemic inﬂ ammatory 
response syndrome (SIRS) or multiple organ failure 
(MOF) [13].
　 Despite signiﬁ cant advances in the development of 
antibiotics,  intensive care unit technology and 
mechanical ventilator support,  sepsis and septic shock 
can be life-threatening conditions.  The incidence of 
these conditions continues to increase [14],  and the 
mortality rate has not signiﬁ cantly improved in the 
past 40 years [15].  The overall mortality rate of 
sepsis is approximately 25 to 35ｵ,  and patients with 
septic peritonitis have a higher mortality rate,  
between 60ﾝ80ｵ [15,  16].  The limited therapeutic 
options are a direct reﬂ ection of our insuﬃ  cient 
knowledge of the pathogenesis of sepsis and septic 
shock.  The key to obtaining in-depth knowledge of the 
pathophysiological disorders is to analyze the molecu-
lar basis of sepsis using animal models of sepsis and 
septic shock.  We employ,  as an animal model of sep-
sis,  a murine model of septic peritonitis induced by 
cecal ligation and puncture (CLP).  CLP is a bacteria-
infection-based sepsis model,  as the host responds to 
the spillage of polymicrobial ﬂ ora in the peritoneal 
cavity [17,  18].  CLP is physiologically relevant to 
human sepsis,  as it possesses a number of the hall-
marks of clinical sepsis with peritonitis associated 
with post-surgical or accidental trauma.
Type-1 and Type-2 Cytokine 
Response during Sepsis
　 Cytokine response is generally divided into 2 types 
based on the distinct cytokine secretion patterns.  The 
response types are termed type-1 (IFNｺ,  TNFｸ) and 
type-2 (IL-4,  IL-5,  IL-13) responses [19].  Evidence 
indicates that the type-1 cytokine response is essential 
in the host defense against bacterial infection [20].  
Recent studies have demonstrated in the CLP model 
that IL-12 (type-1 promoting cytokine) detected in the 
peritoneum is beneﬁ cial for clearing bacteria from the 
peritoneum possibly through the induction of IFNｺ 
[21].  IFNｺ primes/stimulates macrophages to 
increase their responsiveness to bacterial lipopolysac-
charide (LPS),  and induces antibacterial mediators 
such as nitric oxide and TNFｸ [22,  23].  TNFｸ aug-
ments the bactericidal activities of leukocytes,  
enhancing bacterial clearance in several bacterial 
infection models including CLP [21,  24].  Thus,  the 
inﬂ ammatory mediator systems that result in eliciting 
and activating leukocytes appear to be essential to host 
defense in that they restrict the polymicrobial ﬂ ora to 
a local area during infection.  However,  once bacteria 
invade into the body,  type-2 cytokine plays a protec-
tive role in sepsis.  We have found in the CLP model 
that IL-13 (a type-2 cytokine) is not detected in the 
peritoneum,  but is found speciﬁ cally in organs,  and 
the tissue-speciﬁ c IL-13 functions as an immunomodu-
lator of MOF during sepsis [25].  IL-10 is another 
type-2 cytokine that has anti-inﬂ ammatory properties 
[26] and also plays a protective role during CLP by 
down-regulating inﬂ ammatory cytokines [27].  Thus,  
mice with septic peritonitis exhibit a mixed type-1 and 
type-2 cytokine response,  leading to the hypothesis 
that a balanced type-1/type-2 cytokine response may 
be critical in host defense during sepsis.
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STAT Proteins as Transcription Factors 
Mediating Cytokine Signaling
　 STATs consist of STAT1,  STAT2,  STAT3,  
STAT4,  STAT5a,  STAT5b and STAT6.  Each 
member is activated by distinct cytokines.  Cytokines 
bind to homodimeric or heterodimeric receptors,  
which bind JAK proteins.  JAKs are activated by 
transphorylation and then phosphorylate cytokine 
receptors,  allowing STATs to bind via SH2-
phosphotyrosine interactions.  STATs in turn are 
phosphorylated,  and dimerization of activated STATs 
translates to the nucleus where STATs bind DNA and 
regulate gene expression (Fig.  1).  STAT1,  STAT3,  
STAT4 and STAT6 are essential in mediating 
responses to IFNｺ,  IL-10,  IL-12 and IL-13,  respec-
tively [28].
Role of STATs during Sepsis and Septic Shock
　 All STATs have been targeted and the phenotypes 
have been reported.  Studies utilizing gene-targeted 
mice allowed us to explore the biological functions of 
STATs [7,  9].  The phenotypes of mice lacking 
STATs in murine models of sepsis and septic shock 
are summarized in Table 1.
　 STAT1. STAT1 mediates IFNｺ signaling.  
IFNｺ activates peritoneal macrophages,  resulting in 
enhanced bacteria killing,  and protects mice against 
lethal doses of Listeria monocytogenes infection [29,  
30].  Studies using antibodies and gene-knockout mice 
demonstrated that a lack of IFNｺ activities was dele-
terious to the defense against Salmonella typhimurium 
infection [31ﾝ33].  Thus,  IFNｺ plays crucial roles in 
host defense against intracellular pathogens.  However,  
in a polymicrobial septic peritonitis model induced by 
CLP,  neutralizing endogenous IFNｺ conversely 
reduced the mortality that was associated with a 
decrease in HMGB1 release [34],  a 
late mediator of endotoxin lethality 
[35].  The results indicate that IFNｺ 
appears to play a deleterious role dur-
ing the evolution of sepsis.  In a diﬀ er-
ent model of sepsis induced by endo-
toxin,  IFNｺRﾝ/ﾝ mice as well as 
IFNｺﾝ/ﾝ mice were resistant to the 
lethality relative to the wild-type 
(WT) mice,  a result that was associ-
ated with reduced production of TNFｸ [36,  37].  
Since IFNｺ is mediated by STAT1,  it is reasonable 
to speculate that STAT1 may play a role in endotoxin 
shock.  Kamezaki et al. showed that STAT1ﾝ/ﾝ mice 
were moderately resistant to endotoxin shock [37].  
STAT1 can be activated in the liver,  kidney and small 
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Table 1　　Phenotype of mice lacking STATs in endotoxemia and septic peritonitis
STATs Phenotype of Null Mice References
STAT1 resistant to endotoxemia [37]
STAT3＊ susceptible to endotoxemia and septic peritonitis [45,  46]
STAT4 susceptible to endotoxemia/resistant to septic peritonitis [51,  52]
STAT6 susceptible to endotoxemia/resistant to septic peritonitis [51,  52]
＊conditional knockout in macrophages and neutrophils.
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intestine during CLP [38],  but the role of STAT1 in 
bacteria-based sepsis has not been fully determined.
　 STAT3.  STAT3 is a transcription factor that 
mediates IL-10,  a powerful anti-inﬂ ammatory cytokine 
[26].  Enhanced inﬂ ammatory response was shown in 
IL-10ﾝ/ﾝ mice during infection [39ﾝ41].  Although 
STAT3ﾝ/ﾝ mice were embryonic lethal [42],  condi-
tional gene knockout mice allowed us to understand the 
role of STAT3 in immune response.  Riley et al. has 
revealed that STAT3 deﬁ ciency in macrophages and 
neutrophils fails to respond to IL-10 and secretes high 
levels of TNFｸ after stimulation with IL-10 plus 
LPS [43],  suggesting that STAT3 expressed in 
macrophages and neutrophils may negatively regulate 
inﬂ ammatory response.  We have demonstrated that 
resident macrophages,  but not other cell types,  play 
a regulatory role in inﬂ ammation through the STAT3 
signaling pathway,  as mice with a cell-type speciﬁ c 
disruption of the STAT3 gene in macrophages and 
neutrophils exhibited enhanced leukocyte inﬁ ltration 
concomitant with augmented production of inﬂ amma-
tory cytokines after intraperitoneal injection of thio-
glycollate.  Adoptive transfer of resident macrophages 
from the conditional STAT3ﾝ/ﾝ mice into the control 
littermates resulted in an increased number of inﬁ l-
trating leukocytes and elevated peritoneal levels of 
cytokines [44].
　 The conditional STAT3ﾝ/ﾝ mice were highly sus-
ceptible to endotoxemia due to increased levels of 
inﬂ ammatory cytokines including TNFｸ,  IL-1ｹ and 
IFNｺ [45].  The mice also succumbed to septic peri-
tonitis induced by CLP [46].  Although the bacterial 
load in the conditional STAT3ﾝ/ﾝ mice was comparable 
to that in the WT mice,  the mice displayed excessive 
local and systemic inﬂ ammation,  which was accompa-
nied by substantial increases in the level of multiple 
cytokines such as TNFｸ,  IL-1ｹ,  IL-6,  IL-12 and 
IFNｺ.  Elevated serum amyloid A (SAA) and,  in con-
trast,  a decreased albumin level were found in condi-
tional STAT3ﾝ/ﾝ mice.  Both of these ﬁ ndings reﬂ ect 
the severity of the systemic inﬂ ammation.  Hepatic and 
renal injury was signiﬁ cantly exacerbated in the mice 
[46].  Thus,  mice with STAT3 deﬁ ciency in macro-
phages and neutrophils exhibited hypercytokinemia 
during CLP,  leading to uncontrolled excessive local 
and systemic inﬂ ammation resulting in increased 
lethality.  These results suggest that macrophage/
neutrophil-speciﬁ c STAT3 is crucial in not only regu-
lating local inﬂ ammation but also modulating multiple 
organ failure associated with systemic inﬂ ammation.
　 STAT4. Mice lacking IL-12 show impaired 
Th1 diﬀ erentiation,  IFNｺ production and cell-medi-
ated immunity [47].  IL-12-induced increases in the 
production of IFNｺ,  in cellular proliferation and in 
natural killer (NK) cell cytotoxicity are abrogated in 
lymphocytes from STAT4ﾝ/ﾝ mice.  STAT4ﾝ/ﾝ lympho-
cytes demonstrated a propensity towards the develop-
ment of Th2 cells [48].  In addition,  STAT4ﾝ/ﾝ mice 
were resistant to Th1-associated chronic diseases such 
as pulmonary granuloma and experimental autoimmune 
encephalomyelitis (EAE) [49,  50].  Thus,  IL-12/
IFNｺ is essential in Th1 response,  in which STAT4 
plays an important role.  In septic peritonitis induced 
by CLP,  IL-12 was shown to enhance bacterial clear-
ance partly via enhancing IFNｺ production [21],  
which suggests that STAT4ﾝ/ﾝ mice would be suscep-
tible to CLP due to an impaired bacterial clearance.
　 In contrast to this assumption,  STAT4ﾝ/ﾝ mice 
were resistant to the CLP-lethality as compared to the 
WT mice.  There were no diﬀ erences in the numbers 
of inﬁ ltrating neutrophils and macrophages after CLP 
between STAT4ﾝ/ﾝ and WT mice,  and STAT4ﾝ/ﾝ mice 
were burdened with a level of bacteria similar to that 
observed in WT mice [51].  Thus,  the local response 
was not altered in STAT4ﾝ/ﾝ mice.  The mechanism by 
which STAT4ﾝ/ﾝ mice were resistant to CLP appeared 
to be alleviated systemic organ damage.  CLP resulted 
in increases in the serum level of aspartate transami-
nase (AST),  alanine transaminase (ALT),  blood urea 
nitrogen (BUN) and creatinine in WT mice.  However,  
these levels were strongly decreased in STAT4ﾝ/ﾝ 
mice,  and the levels were comparable to those in 
untreated mice.  Hepatic inﬂ ammation was dramati-
cally attenuated in STAT4ﾝ/ﾝ mice,  as assessed by 
myeloperoxidase (MPO) level and histology.  Tissue 
levels of type-2 cytokine IL-10 and IL-13 in STAT4ﾝ/ﾝ 
mice were signiﬁ cantly augmented in the liver,  as 
compared to WT mice,  whereas the levels of macro-
phage inﬂ ammatory protein (MIP)-2 and KC,  CXC 
chemokines known to attract and activate neutrophils 
were markedly lower in the liver and kidney of 
STAT4ﾝ/ﾝ mice than those of WT mice.  These results 
indicate that the cytokine proﬁ le in the organs during 
sepsis was altered in STAT4ﾝ/ﾝ mice in favor of anti-
inﬂ ammatory properties,  which may contribute to the 
improvement of organ injury,  resulting in an 
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increased survival in STAT4ﾝ/ﾝ mice.  On the other 
hand,  Lentsch et al. reported in an endotoxemia model 
that STAT4ﾝ/ﾝ mice showed increased susceptibility to 
sepsis due to an elevated IL-12 level in the circulation 
[52].  The discrepancies may be explained by the sub-
stantial diﬀ erences in the complexity between the 
infectious and noninfectious models.
　 STAT6. Naive CD4＋ T cells diﬀ erentiate into 
Th2 cells via STAT6 when stimulated with IL-4 [53].  
IL-13 is also capable of activating STAT6 [54],  and 
the macrophage functions in response to IL-13 are 
impaired in STAT6ﾝ/ﾝ mice [55].  IL-4 and IL-13 are 
anti-inﬂ ammatory cytokines,  inhibiting the production 
of pro-inﬂ ammatory cytokines such as TNFｸ,  which 
are known to play a deleterious role in endotoxemia.  
STAT6ﾝ/ﾝ mice were highly susceptible to lethal endo-
toxemia,  a result of the augmented production of pro-
inﬂ ammatory cytokines and chemokines that can lead 
to increased organ inﬂ ammation and damage [52].  We 
have shown in the CLP model that IL-13 detected 
speciﬁ cally in tissues protects mice from CLP-
induced lethality by modulating inﬂ ammatory 
responses via the suppression of the overzealous pro-
duction of inﬂ ammatory cytokines/chemokines [25].  
These results led us to speculate that STAT6ﾝ/ﾝ mice 
would be susceptible to CLP due to an enhanced 
inﬂ ammatory response that causes severe organ dam-
age.
　 Unexpectedly,  survival rates after CLP in 
STAT6ﾝ/ﾝ mice were signiﬁ cantly higher than in WT 
mice [51].  Interestingly,  the bacterial load recovered 
from the peritoneal cavity in STAT6ﾝ/ﾝ mice was sig-
niﬁ cantly lower than that in WT mice.  The number of 
neutrophils after CLP in STAT6ﾝ/ﾝ mice was signiﬁ -
cantly increased as compared to WT mice.  These data 
suggest that the host defense at the site of infection 
was augmented in STAT6ﾝ/ﾝ mice.  In vitro,  no diﬀ er-
ence was found in the activation of leukocytes by mea-
suring lysosomal enzyme release and superoxide anion 
(O2ﾝ) generation after stimulation with LPS or E.  coli,  
suggesting that STAT6ﾝ/ﾝ mice cleared bacteria more 
eﬀ ectively than WT mice based on the situation of the 
cells.  Peritoneal levels of IL-12 and TNFｸ were sig-
niﬁ cantly higher in STAT6ﾝ/ﾝ mice,  as compared to 
WT mice.  IL-12 and TNFｸ are capable of enhancing 
bacteria clearance in several infection models includ-
ing septic peritonitis [21,  24].  Treatment of 
STAT6ﾝ/ﾝ mice with anti-IL-12 or anti-TNFｸ neutral-
izing antibodies increased the bacterial load in the 
peritoneum.  Administration of anti-TNFｸ abrogated 
the increased number of neutrophils observed in 
STAT6ﾝ/ﾝ mice.  Peritoneal levels of CCL22 (macro-
phage-derived chemokine/MDC) and CCL6 (C10),  
which are known to exhibit a strong type-1 response 
during CLP [17,  56],  were also augmented in 
STAT6ﾝ/ﾝ mice.  Altogether,  these results indicate 
that STAT6ﾝ/ﾝ mice were resistant to CLP due to an 
altered cytokine proﬁ le in the peritoneum in favor of 
a type-1 response,  possibly due to the type-1/type-2 
cytokine balance.  The enhanced type-1 response in 
STAT6ﾝ/ﾝ mice was also demonstrated in other stud-
ies.  STAT6ﾝ/ﾝ mice were resistant to infection against 
Leishmania mexicana via the development of a type-1 
cytokine response [57].  The induction of experimen-
tal autoimmune encephalomyelitis (EAE),  a Th1-
associated response,  was exaggerated in STAT6ﾝ/ﾝ 
mice [49].
Negative Regulation of STATs by SOCS 
Proteins in Sepsis and Septic Shock
　 The JAK/STAT signal transduction pathway is 
negatively regulated by SOCS proteins [10,  58].  
Recent studies indicate that SOCS proteins are impli-
cated in a variety of immune and inﬂ ammatory dis-
eases [8].  SOCS1ﾝ/ﾝ mice were highly sensitive to 
LPS-induced shock because of an increased serum 
level of TNFｸ [59,  60].  The introduction of SOCS1 
inhibited LPS-induced NF-κB and STAT1 activation 
in macrophages.  In addition,  LPS tolerance,  a 
refractory state to second LPS stimulation,  was not 
observed in SOCS1ﾝ/ﾝ mice [59,  60].  Thus,  SOCS1 
negatively regulates LPS responses.  Gene delivery of 
SOCS3 protected mice from lethal endotoxemia by 
decreasing the serum level of TNFｸ [61].  These 
results suggest that SOCS1 and SOCS3 may be new 
targets for the treatment of endotoxin-induced shock 
syndrome that occasionally occurs following infection.
　 Very recently,  we demonstrated that mice with a 
cell-speciﬁ c overexpression of SOCS5 in T cells 
(SOCS5Tg) are resistant to the lethality relative to 
the WT mice [62].  The bacterial burden in 
SOCS5Tg mice was signiﬁ cantly lower than in WT 
mice,  and the accumulation of leukocytes was aug-
mented in SOCS5Tg mice,  which was accompanied by 
increased peritoneal levels of IL-12,  IFNｺ and TNFｸ.  
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In vitro bactericidal activities of macrophages and neu-
trophils were enhanced in SOCS5Tg mice.  Both neu-
trophils and macrophages from WT mice showed 
enhanced bacterial killing activity when co-cultured 
with CD4＋ T cells from SOCS5Tg mice,  relative to 
CD4＋ T cells from WT mice.  Furthermore,  the 
CLP-induced bacterial burden in T- and B-cell-
deﬁ cient RAG-2ﾝ/ﾝ mice harboring SOCS5Tg-CD4＋ T 
cells was signiﬁ cantly reduced relative to the controls 
[62].  These ﬁ ndings provide evidence that SOCS5 in 
T cells aﬀ ects innate immunity,  and thus they high-
light a novel role of T cells during sepsis.  Further 
studies are necessary to elucidate the contribution of 
T cells to the initiation of innate immunity.
Concluding Remarks
　 The remedy for sepsis and septic shock remains 
unknown.  Recent clinical trials aimed at modulating 
inﬂ ammatory response have failed or shown only mod-
est clinical beneﬁ t.  Although the local inﬂ ammatory 
response may be viewed as an unwelcome event follow-
ing infection because of the unpleasant clinical symp-
toms (redness,  heat,  swelling and pain),  the response 
is clearly a beneﬁ cial protective host response in the 
maintenance of health,  which can be strengthened by 
STAT6 deactivation.  However,  excessive systemic 
inﬂ ammation is fatal to the host.  Such inﬂ ammation 
can be weakened by STAT4 deactivation and in con-
trast STAT3 activation.  Thus,  therapeutic eﬀ orts 
aimed at regulating the STATs may represent a new 
therapeutic intervention for patients with sepsis or 
SIRS,  which can be controlled by SOCSs.  Innate 
immune response is tightly linked to acquired immune 
response,  and STATs/SOCSs are essential to the 
linkage.  Augmenting the innate responses by regulat-
ing STATs/SOCSs has the potential to promote 
immediate eﬀ ects,  as well as to deliver beneﬁ cial 
eﬀ ects to the most beneﬁ cial downstream adaptive 
responses for defense against particular pathogens.
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